STAT3-CCL2 signaling, which is activated by FAP, promoted tumor growth by enhancing the recruitment of MDSCs (CD11b+Gr1+) and macrophages, both of which express the CCR2 receptor, thus preventing antitumor IFNγ-T-cell immunity. Here, CCL2 is linked to neoplasm.